A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.
C. David Klingman, PhD
Advertisement
Articles by C. David Klingman, PhD
Advertisement
Latest Updated Articles
- Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients
Published: September 7th 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
3
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
4
Smartphone App Reduces Depression in Adults With Intellectual Disabilities
5
